Rigel Pharmaceuticals Inc (RIGL)
Depreciation & Amortization
$848.00K
Quarterly · Period ending: · USD
RIGL Depreciation & Amortization
Latest reported$848.00Kperiod ending
Latest reported$848.00Kperiod ending
RIGL Quarterly Depreciation & Amortization ($1.91M → $848.00K)
Quarterly Depreciation & Amortization
High-resolution chart · PNG
RIGL depreciation & amortization history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Depreciation & Amortization (USD) |
|---|---|
| 848,000 | |
| 597,000 | |
| 601,000 | |
| 603,000 | |
| 607,000 | |
| 604,000 | |
| 604,000 | |
| 611,000 | |
| 613,000 | |
| 400,000 | |
| 293,000 | |
| 292,000 | |
| 296,000 | |
| 357,000 | |
| 284,000 | |
| 240,000 | |
| 237,000 | |
| 237,000 | |
| 404,000 | |
| 261,000 | |
| 258,000 | |
| 239,000 | |
| 206,000 | |
| 165,000 | |
| 164,000 | |
| 171,000 | |
| 180,000 | |
| 166,000 | |
| 173,000 | |
| 164,000 | |
| 163,000 | |
| 159,000 | |
| 159,000 | |
| 113,000 | |
| 113,000 | |
| 112,000 | |
| 114,000 | |
| 126,000 | |
| 143,000 | |
| 214,000 | |
| 260,000 | |
| 324,000 | |
| 338,000 | |
| 287,000 | |
| 379,000 | |
| 435,000 | |
| 507,000 | |
| 574,000 | |
| 623,000 | |
| 655,000 | |
| 651,000 | |
| 644,000 | |
| 628,000 | |
| 669,000 | |
| 636,000 | |
| 635,000 | |
| 610,000 | |
| 552,000 | |
| 526,000 | |
| 506,000 | |
| 476,000 | |
| 447,000 | |
| 393,000 | |
| 327,000 | |
| 292,000 | |
| 305,000 | |
| 346,000 | |
| 365,000 | |
| 372,000 | |
| 320,000 | |
| 361,000 | |
| 354,000 | |
| 368,000 | |
| 342,000 | |
| 335,000 | |
| 335,000 | |
| 338,000 | |
| 336,000 | |
| 429,000 | |
| 325,000 | |
| 330,000 | |
| 334,000 | |
| 480,000 | |
| 113,000 | |
| 276,000 | |
| 311,000 | |
| 718,000 | |
| 491,000 | |
| 537,000 | |
| 627,000 | |
| 652,000 | |
| 699,000 | |
| 823,000 | |
| 1,003,000 | |
| 1,376,000 | |
| 1,261,000 | |
| 1,465,000 | |
| 1,722,000 | |
| 1,733,000 | |
| 1,634,000 |